The role of metal ions in dopaminergic neuron degeneration in Parkinsonism and Parkinson’s disease

Abstract

Parkinson’s disease is characterized by the selective degeneration of neuromelanin-containing dopaminergic neurons in the substantia nigra and locus coeruleus. Although the cause of this disease remains unknown, several transition metals, including manganese and copper, have been associated with the development of the atypical form of Parkinsonism, and iron accumulation has been associated with the development of Parkinson’s disease. Manganese3+ is a strong oxidizing agent, which oxidizes dopamine to aminochrome (dopaminochrome), the precursor of neuromelanin. Aminochrome formation in cell culture medium induces acute cell death in cells that uptake aminochrome, explaining the role of manganese in the development of atypical Parkinsonism. Copper accumulation in Wilson’s disease also induces Parkinsonism as one of the main symptoms, and an atypical Parkinsonism has also been observed in young copper miners. Interestingly, copper is able to complex with dopamine, which can be taken up by cells expressing the dopamine transporter, inducing caspase-independent cell death with formation of autophagic vacuoles. Iron is also able to form a complex with dopamine, the neurotoxic action of which also depends on the cellular expression of the dopamine transporter. The neurotoxicities of these transition metals to cells expressing the dopamine transporter all involve dopamine oxidation to quinones and require the inhibition of DT-diaphorase.